SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following a strong earnings report that showcased robust revenue growth and adjusted net income reaching breakeven, signaling strong execution in the AI infrastructure sector. The community is actively discussing these impressive results, particularly advanced negotiations for substantial new hyperscaler capacity, even as perplexing price movements lead to debates about market manipulation versus a prime buying opportunity. This focus on rapid expansion and growing demand for AI data centers underpins strong long-term sentiment.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid intense, politically charged discussions surrounding a controversial ICE-involved shooting in Minneapolis that resulted in a woman's death. Community members are sharply divided, with some echoing former President Trump's defense of the agent's actions as justified, while others are condemning it as murder and demanding accountability. This polarizing event is fueling fervent debate among commentators and impacting broader conversations around the stock.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp (OMER) is a major talking point after receiving FDA approval for Yartemlea, the first treatment for transplant-associated thrombotic microangiopathy, with its market launch quickly following. The community is actively discussing the drug's projected high per-patient treatment cost and its potential to become a standard of care, driving considerable excitement about future revenue and potential analyst upgrades.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX NASDAQ is trending amidst fervent community discussion centered on its extremely low share float and high short interest, leading to strong expectations of a potential short squeeze. Traders are actively comparing its setup to past high-volatility runners, with many anticipating substantial price appreciation while some express caution regarding potential dilution and the stock's historical volatility. The company's blockchain-based Plastic Cycle Token and digital DNA technology provide an underlying narrative for long-term potential.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending due to a political announcement targeting institutional purchases of single-family homes, triggering a significant sell-off and intense debate. Many in the community believe this news is actually bullish for Opendoor, arguing its iBuying model facilitates individual homeownership and will benefit from reduced institutional competition. However, others remain concerned, leading to divided perspectives on the company's future trajectory despite the CEO's clarifying statements.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is generating significant buzz following reports that JPMorgan has sealed a deal to take over its credit card operations, a move largely welcomed by the community. Despite this, the stock is noticeably lagging the broader market, triggering frustration among investors who are questioning Apple's innovation trajectory, particularly concerning AI and the initial reception of its new headset. Traders are keenly watching for support levels, debating whether the recent dip offers a prime buying opportunity or signals further weakness.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

Immuneering Corp

Immuneering is trending following the release of updated data for its pancreatic cancer treatment, showing a significant improvement in overall survival compared to the historical benchmark. Community perspectives are notably divided; many highlight the strong clinical benefit and improved quality of life, while others express disappointment that the reported 64% survival rate did not meet elevated market expectations. This mixed reaction is driving conversation around the stock's valuation, potential acquisition interest, and its robust funding for upcoming pivotal trials, despite comparisons to other oncology therapies.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending following a pre-production order for GPU-accelerated compute systems aimed at enhancing situational awareness in U.S. Army combat vehicles, alongside a strategic asset sale to focus on core AI/edge compute. The community is buzzing with anticipation for a larger defense contract, fueled by the company's strong fundamentals, recent profitability, and perceived undervaluation in the rapidly growing AI and defense sectors.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is experiencing heightened trading activity driven by contrasting announcements from former President Trump, initially facing sell-offs on proposed dividend restrictions before surging on calls for a substantially increased military budget. This market volatility is compounded by news of a significant agreement to triple PAC-3 missile production, sparking community debate over market influence and defense sector growth.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is actively trending as investors react to a recent downgrade from Cantor Fitzgerald, which many in the community dismiss as manipulation designed to shake out retail holders. Bulls are highlighting the company's recent debt reduction and Ask Sage acquisition as foundational for securing upcoming large government AI contracts. The ongoing debate centers on whether the current dip presents a buying opportunity before anticipated contract announcements in the defense AI sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Down 29.4% in December

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totaling 220,276 shares...

Gregg Williams Acquires 1,737,765 Shares of Vivani Medical (NASDAQ:VANI) Stock

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams acquired 1,737,765 shares of Vivani Medical stock in a transaction that occurred on Monday, December 15th. The shares were...

FY2025 EPS Estimates for Vivani Medical Boosted by Analyst

Vivani Medical, Inc. (NASDAQ:VANI - Free Report) - Investment analysts at HC Wainwright upped their FY2025 earnings per share estimates for shares of Vivani Medical in a research report issued on...

Vivani Medical (NASDAQ:VANI) Upgraded to "Sell" at Wall Street Zen

Wall Street Zen raised Vivani Medical to a "sell" rating in a research report on Saturday...

Gregg Williams Purchases 1,737,764 Shares of Vivani Medical (NASDAQ:VANI) Stock

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 1,737,764 shares of Vivani Medical stock in a transaction on Saturday, November 15th. The stock was purchased at...

Vivani Medical (NASDAQ:VANI) Director Gregg Williams Acquires 1,737,764 Shares

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams acquired 1,737,764 shares of Vivani Medical stock in a transaction dated Saturday, November 15th. The shares were bought...

Vivani Medical (NASDAQ:VANI) Upgraded to Hold at Zacks Research

Zacks Research raised shares of Vivani Medical from a "strong sell" rating to a "hold" rating in a report on Wednesday...

Vivani Medical (NASDAQ:VANI) Issues Earnings Results, Beats Estimates By $0.01 EPS

Vivani Medical (NASDAQ:VANI - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.11) EPS for the quarter, beating analysts' consensus estimates of ($0.12...

Vivani Medical (VANI) Projected to Post Earnings on Wednesday

Vivani Medical (NASDAQ:VANI) will be releasing its Q3 2025 earnings before the market opens on Wednesday, November 12. (View Earnings Report at...

Vivani Medical, Inc. (VANI), on Wednesday, <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.vivani.com/investors/news-events/press-releases/detail/188/vivani-medical-announces-positive-preclinical-weight-loss">announced</a> promising preclinical data for its semaglutide implant in development for weight management in overweight patients.NPM-139 is a small, subdermal semaglutide implant. Semaglutide is the active ingredient in popular weight-loss drugs such as Ozempic or Wegovy.Vivani Medical CEO Adam Mendelsohn said products containing semaglutide generated $25 billion in 2024, and demand for these products continues to soar.“Since over half of these patients regularly miss doses as indicated by real-world medication adherence data, we believe that there is a tremendous opportunity for a more convenient delivery option that will eliminate missed doses and thereby improve real-world health outcomes,” he said.The company said on Wednesday that a single administration of the implant in healthy rats resulted in 20% lower body weight through a 91-day treatment period as compared to a control group that received a sham implant.NPM-139 is being initially developed as a twice-yearly implant but has the potential benefit of once-yearly administration, the company said.The company also said it recently successfully implanted an initial group of human subjects with NPM-115, a miniature, ultra long-acting exenatide implant aimed at overweight persons.Data from the study of NPM-115 is expected to be available mid-2025. The study is also expected to pave the way for the development of NPM-139, the company said.On Stocktwits, retail sentiment about Vivani rose from ‘bullish’ to ‘extremely bullish’ territory while message volume jumped from ‘low’ to ‘high’ in the past 24 hours.<figure class="image"><img style="aspect-ratio:649/150;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_26_at_1_56_56_PM_png_deb5769989.webp" alt="VANI's Sentiment Meter and Message Volume as of 1:55 p.m. ET on March 26, 2025 | Source: Stocktwits" width="649" height="150"><figcaption>VANI's Sentiment Meter and Message Volume as of 1:55 p.m. ET on March 26, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits commended the company’s idea of implants, taking out the need for daily pills or injections.<stembedurl>https://stocktwits.com/ZabDad/message/609254484</stembedurl>Brokerage H.C. Wainwright said on Wednesday that the preclinical data validates the versatility of the company’s proprietary NanoPortal implant technology while reiterating a ‘Buy’ rating on the shares with a price target of $4.A Stocktwits user, however, highlighted the company’s low cash. As of Sept. 30, 2024, Vivani had cash, cash equivalents, and restricted cash totaling $21 million.<stembedurl>https://stocktwits.com/Earl40/message/609298832</stembedurl><a href="https://stocktwits.com/symbol/VANI">VANI shares</a> traded nearly 2% higher on Wednesday afternoon. The stock is down over 6% this year and by over 40% in the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/rivian-spins-off-micromobility-business-into-new-company-also/chJbT8iRb3m">Rivian Spins Off Micromobility Business Into New Company ‘Also’: Retail’s Elated</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A tape measure lies on a scale while a young woman buries her head in her hands in the background. (Photo by Pia Bayer/picture alliance via Getty Images)

Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars

The company said on Wednesday that a single administration of the implant in healthy rats resulted in 20% lower body weight through a 91-day treatment period as compared to a control group that received a sham implant. 

Equity

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Vivani Medical Inc

SpaceX

Discord

OpenAI

Other - Comment Below

A few major private companies are being discussed as potential IPO candidates in 2026 — including SpaceX, Discord, Databricks, OpenAI, Anthropic, and Deel. IPO timelines can shift, but if one of these listings happens this year, which are you most excited to watch?

Which Potential 2026 IPO Are You Most Excited For?

VANI
Vivani Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest VANI News

VANIVivani Medical Inc